OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Gastroenterology and Hepatology is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Editorial Board	531
Front Cover	417
Hepatic Artery Pseudoaneurysm After Whipple Procedure	302
Table of Contents	299
Blue Notes	287
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	269
Blue Notes	240
FODMAPs in IBS: Revisiting Restriction	218
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	208
hEDS and the Nosology of Disorders of Gut Brain Interaction	201
Symptom-Based Testing and Eradication of Helicobacter pylori and Risk of Gastric Cancer	191
Assessment and Significance of Histologic Activity in Crohn’s Disease	191
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	186
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease	180
Chronic Kidney Disease Does Not Influence Response to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury	176
Who Examines the Colon Matters More Than What Is Removed	165
Perianal Disease in Pediatric-onset Crohn’s Disease: Incidence, Disease Course, and Long-term Outcomes	160
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	140
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	140
Update in the Treatment of the Complications of Cirrhosis	138
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	128
Editorial Board	127
Correction	127
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	122
Associations Between Sexual Orientation and Disorders of Gut-brain Interaction in Sexual Minority Populations	119

Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	118
Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection	118
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	118
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	117
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	116
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	114
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	111
Association Between Index Adenomas and Advanced Findings at Third Colonoscopy: Data From the New Hampshire Colonoscopy Registry	110
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	109
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	109
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	108
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	108
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient in Clinical Practice: An Investigational Procedure—What Can We Tell Patients?	105
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	104
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	103
AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study	102
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	102
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	101
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	99
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	95
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	94
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	91
Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial	90
Elsewhere in the AGA Journals	90
Reply	89
Editorial Board	86
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	86
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	85
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	84
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	84
Attribution of Colonoscopy Risk Does Not FIT!	83
Reply	83
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	83
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	82
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	81
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	81
Reply	79
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	79
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	78
Blue Notes	78
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	78
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	77
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	77
Table of Contents	77
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	76
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	75
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	74
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	73
Front Cover	73